(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyric acid

We are (2S,3R)-3-Amino-2-hydroxy-4-phenylbutyric acid CAS:59554-14-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  (2S,3R)-3-Amino-2-hydroxy-4-phenylbutyric acid
CAS.NO:   59554-14-2
Synonyms:
3-Amino-2-Hydroxy-4-Phenylbutyric Acid

Molecular Formula: C10H13NO3
Molecular Weight:  195.21500

Physical and Chemical Properties:
Density:  1.285 g/cm3
Boiling point: 428.5ºC at 760 mmHg
Melting point: /
Flash point: 213.0±28.7 °C
Refractive index:1.595

Specification:
Appearance: white powder
Purity:≥99.0%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:
Storage:2°C-8°C.Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application: 
Intermediates of Ubenimex CAS:58970-76-6.

Related News: With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.N-Methyl-N-(4-nitrophenethyl)-2-(4-nitrophenoxy)ethanamine CAS:115287-37-1 With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.101968-85-8 With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.1,3-Dichloro-5-fluorobenzene CAS:1435-46-7 Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.